PCVX - Vaxcyte announces commencement of proposed public offering January, 30 2024 04:20 PM Vaxcyte Inc. 2024-01-30 16:20:57 ET More on Vaxcyte Vaxcyte: Looking Fully Valued Vaxcyte slips after pipeline updates Vaxcyte's pneumococcal shot shows safety profile comparable to Pfizer's Prevnar 20 Seeking Alpha’s Quant Rating on Vaxcyte Historical earnings data for Vaxcyte For further details see: Vaxcyte announces commencement of proposed public offering